Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer
Authors:
Open Access
- 2 June 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 112 (1) , 143-149
Abstract
Vesicular stomatitis virus (VSV) has been shown to replicate rapidly in vitro and kill selectively a variety of tumor cell lines. The present study was designed to determine whether gemcitabine potentiates the antitumor activity of VSV in vitro and in vivo. A549 human lung adenocarcinoma cells and LLC Lewis lung carcinoma cells were treated with VSV (0.1–10 plaque‐forming units per cell) plus gemcitabine (20 nM to 20 μM). Mice bearing A549 or LLC were treated with VSV (5 × 104 to 1 × 108 plaque‐forming units) daily for 5 days plus gemcitabine (5–125 mg/kg/day) once every 3 days for 4 times. Induction of apoptosis and effects on growth inhibition were assessed. The lung cancer cells treated with VSV plus gemcitabine displayed the apparently increased apoptotic cells compared with treatment with VSV or gemcitabine alone. The combined treatment with VSV plus gemcitabine induced the apparent antitumor activity with complete regression of the established lung cancer in both A549 and LLC lung cancer models and augmented the induction of apoptosis in lung cancer cells in vivo as well. This study suggests that the combined treatment with VSV plus gemcitabine may augment the induction of apoptosis in lung cancer cells in vitro and in vivo, and that the augmented antitumor activity in vivo may result from the increased induction of apoptosis in lung cancer cells. The present findings may be of importance to the further exploration of the potential application of this combined approach in the treatment of lung cancer.Keywords
This publication has 20 references indexed in Scilit:
- Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-groupLung Cancer, 2003
- Requirement of caspase-3 for efficient apoptosis induction and caspase-7 activation but not viral replication or cell rounding in cells infected with vesicular stomatitis virusHuman Immunology, 2003
- A gene therapy for cancer based on the angiogenesis inhibitor, vasostatinGene Therapy, 2002
- Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II studyAnnals of Oncology, 2001
- Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer.European Journal of Cancer, 2001
- Emerging therapies in non-small-cell lung cancerAnnals of Oncology, 2001
- Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancerSeminars in Oncology, 2001
- High dose radiation therapy and chemotherapy as induction treatment for Stage III nonsmall cell lung carcinomaCancer, 2000
- Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virusNature Medicine, 2000
- In situ observation of inflammatory cell-tumor cell interaction in human seminomas (germinomas): Light, electron microscopic, and immunohistochemical studyHuman Pathology, 1992